Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

3 Strong Buy Stocks to Continue to Hold Onto in 2023

As the Fed’s aggressive monetary policy resulted in slightly cooled inflation last month, investors are hopeful of smaller rate hikes ahead. However, since a recession is expected to hit the economy next year, we think fundamentally sound stocks Pfizer (PFE), Flowers Foods (FLO), and Xperi (XPER), which are rated Strong…

StockNews.com

Boy, 14, died three weeks after having Covid vaccine

A coroner has said there will be a 'considerable investigation'

Wales Online

US renews push for COVID boosters as data show they protect

Americans who have gotten the updated COVID-19 boosters appear better protected against symptomatic infection than those who haven't — at least for now

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Death of boy, 14, three weeks after Covid jab of 'significant public concern' - coroner

Joseph McGinty died at home on Achill Island in County Mayo, Ireland, three weeks after receiving the Pfizer Covid-19 jab, with a coroner describing the death as a "significant public concern"

Daily Mirror

Intellectual property waiver for COVID vaccines should be expanded to include treatments and tests

Global inequities in access to COVID vaccines have turned out to be a “catastrophic moral failure”, just as the World Health Organization warned they would in January 2021. Yet it took 20 months of negotiations for members of the World Trade Organization (WTO) to agree to a limited relaxation of…

The Conversation

RSV: experts explain why rates of this virus are surging this year

Respiratory syncytial virus (RSV) is a very common virus, typically causing infection in children during the colder months. In most cases, RSV causes a mild illness, with symptoms similar to that of a regular cold.

The Conversation

Elizabeth Holmes: What convictions and acquittals led up to her sentencing

Theranos founder Elizabeth Holmes walked into her criminal trial in federal court in San Jose in September 2021 charged with 12 counts of fraud in connection with her now-defunct Palo Alto blood-testing startup. Four months later, she walked out guilty on four counts, after a jury found her liable for…

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Pfizer booster spurs immune response to new omicron subtypes

Pfizer said its updated COVID-19 booster may offer some protection against newly emerging omicron mutants even though it’s not an exact match

The Independent UK

Pfizer/BioNTech's updated COVID shot shows strong response against BQ.1.1

Pfizer Inc and its German partner BioNTech SE said on Friday their Omicron-tailored shot produced higher virus-neutralizing antibodies in older adults against the emerging subvariant BQ.1.1 than its original vaccine.

Reuters

German panel recommends COVID shot only for at-risk youngsters

Germany's vaccine advisory panel on Thursday recommended that Pfizer-BioNTech's COVID-19 vaccine for children from six months to four years should only be given routinely to those at risk of severe disease from the infection.

Reuters

The Futuristic Promise of Dippin' Dots

The ice cream's innovative freezers helped Pfizer keep COVID-19 vaccines stable during transit.

Reason

California programs are waiting weeks for free Narcan to prevent overdose deaths

LOS ANGELES — After losing her son Luke to an overdose, Sheila Scott has been trying to get "revenge on death," she said.

Los Angeles Times

A New Omicron-Specific Booster Is Coming To Australia Next Month So Here’s What The Go Is

ATAGI gave the new Pfizer jab the all-clear on Tuesday.

Pedestrian.tv

Pfizer's new Omicron-specific COVID booster to be available in Australia from next month

Another bivalent COVID-19 vaccine will be available to eligible Australians as a third and fourth booster, as case numbers climb.

ABC News

Get all your
news in one place.

100's of premium titles.
One news app.

The New Daily

‘Next-generation’ COVID vaccine with double protection approved as cases spike

Medical authorities have approved a new COVID vaccine for use in Australia that offers protection from two strains of the virus.

AAP

Experts rule out third COVID booster shot

Despite a spike in COVID-19 cases, the country's leading vaccine advisory body says Australians don't yet need a fifth dose of vaccine.

StockNews.com

3 Dividend Stocks to Buy to Help Soothe Some of Your Pain

Although inflation eased slightly last month, the Fed has indicated that the final level of interest rates could be higher than expected. With further interest rate hikes and the possibility of a recession expected to keep the market under pressure, it could be wise to buy dividend-paying stocks Pfizer (PFE),…

The Denver Post

COVID-19 booster uptake remains low, despite growing evidence they’re as good as older shots

DENVER — More than two months into the campaign to get people to take updated COVID-19 boosters, only about 8% of people who are eligible have received the shot, though about 23% of those 65 and older have, according to Centers for Disease Control and Prevention estimates.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Ireland has raked in billions from tech giants. But what if the golden goose flies the nest?

The republic’s welcoming corporate tax policy has been a success, but it depends heavily on just a few big names

StockNews.com

Could Pfizer Stock Help You Retire a Millionaire?

Leading biopharmaceutical company Pfizer’s (PFE) third-quarter results demonstrated strength across most areas of its business. Moreover, the company raised its 2022 financial guidance for revenues and adjusted EPS. Also, the company has increased its dividend for 12 consecutive years, and its annual dividend yields more than 3%. Given its solid…

StockNews.com

3 Stocks Wall Street Loves

Amid the ongoing macroeconomic and geopolitical issues, the stock market has faced wild swings this year. As the sky-high inflation and the Fed’s aggressive rate hikes continue to heighten recessionary fears, Wall Street darlings Microsoft (MSFT), Pfizer (PFE), and Coca-Cola (KO), which have a solid dividend-paying record, might be ideal…

Reuters

European regulator recommends Pfizer's Omicron booster for children

Pfizer Inc and its partner BioNTech said on Thursday the EU health regulator has recommended authorising the use of their bivalent COVID-19 shot as a booster in children aged 5 through 11.

Benzinga

Mark Zuckerberg Takes Blame As Meta Lays Off 13% Of Workforce, Elon Musk's Tesla Stock Sale May Not Sit Well With Investors, Netflix Eyes Sports Leagues: Top Stories Wednesday, Nov. 09

Benzinga

Tribune News Service

Pfizer’s COVID cash powers a ‘marketing machine’ on the hunt for new supernovas

For drugmaker Pfizer, a fortune amassed in the COVID pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions.

Wales Online

Pfizer boss labels Covid a 'multibillion-dollar franchise' as vaccine cost set to soar

Chief financial officer David Denton reportedly told investors at the drug maker that he expects profits will continue to rise

1 … 32 33 34 35

People

Dipanjan BanchurSince

722 stories

Luke

615 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.